Clinical Trials · NCT00004895

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

CompletedPhase 2Octreotide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Northwestern University
Enrollment
0
Start date
Oct 1999
Locations
1 site, United States
Primary endpoint
Study in Colorectal Cancer
View Octreotide compound reference